European Journal of Obstetrics & Gynecology and Reproductive Biology 2001: Vol 95 Index

5 Pages·2001·0.82 MB·English

EUROPEAN JOURNAL OF
OBSTETRICS &
GYNECOLOGY
European Journal of Obstetrics & Gynecology and AND REPRODUCTIVE BIOLOGY
Reproductive Biology 95 (2001) 233-235
www.elsevier.com/locate/ejogrb
Author index
Volume 95 (2001)
Aardenburg, R., see Spaanderman, M.E.A. 95, 218 Crépin, G., see Cosson, M. 95, 73
Afonne, O.J., see Orisakwe, O.E. 95, 92 Crescimbini, B., see Zuppa, A.A. 95, 68
Aguilar-Galan, E.V., see Benito-Leon, J. 95, 181 Cugnenc, P.-H., see Berger, A. 95, 111
Ankum, W.M., see Engelsbel, S. 95, 81 Curvers, J., Nienhuis, S.J., Nap, A.W., Hamulyak, K., Evers, J.L.H., Rosing,
Asomugha, L., see Orisakwe, O.E. 95, 92 J., Activated protein C resistance during in vitro fertilization treat-
ment 95, 222
Bakas, P., see Liapis, A. 95, 97 Curvers, J., see Rosing, J. 95, 193
Baltaci, V., see Ergin, T. 95, 37 Czeizel, A.E., Rockenbauer, M., Sorensen, H.T., Olsen, J., Nitrofurantoin
Batioglu, S., see Ergin, T. 95, 37 and congenital abnormalities 95, 119
Bebar, S., see Ursié Vrscaj, M. 95, 105
Belfort, M.A., see Vedernikov, Y.P. 95, 46 Danel, C., see Berger, A. 95, 111
Benito-Leon, J., Aguilar-Galan, E.V., Recurrent myotonic crisis in a Danti, L., see Soregaroli, M. 95, 42
pregnant woman with myotonic dystrophy 95, 181 de Groot, C.J.M., see Bloemenkamp, K.W.M. 95, 225
Benzi, G., see Di Cintio, E. 95, 132 de Leeuw, P.W., see Spaanderman, M.E.A. 95, 218
Berger, A., Rouzier, R., Carnot, F.V., Braunberger, E., Cugnenc, P.-H., Dekker, G.A., see Bolte, A.C. 95, 12, 22
Danel, C., Primary adenocarcinoma of the rectovaginal septum: a case Di Cintio, E., Parazzini, F., Chatenoud, L., Surace, M., Benzi, G.,
report and literature review 95, 111 Zanconato, G., La Vecchia, C., Dietary factors and risk of spontaneous
Berkane, N., see Merviel, P. 95, 59 abortion 95, 132
Bertina, R.M., Genetic aspects of venous thrombosis 95, 189 Dinnes, J., see Khan, K.S. 95, 6
Bertina, R.M., see Bloemenkamp, K.W.M. 95, 225 Dioka, C.E., see Orisakwe, O.E. 95, 92
Bloemenkamp, K.W.M., de Groot, C.J.M., Ronde, H.D., Duvekot, E.J., Djurisic, A., see UrSié Vrscaj, M. 95, 105
Helmerhorst, F.M., Bertina, R.M., The effect of factor V Leiden, Duran, E. Hakan, see Ergin, T. 95, 37
oral contraceptive use, type of oral contraceptives and pregnancy on Duvekot, E.J., see Bloemenkamp, K.W.M. 95, 225
APC-r levels in women with or without a history of pre-eclampsia 95,
225
Ekhart, T.H.A., see Spaanderman, M.E.A. 95, 218
Bolte, A.C., van Geijn, H.P., Dekker, G.A., Pathophysiology of preeclamp-
El-Refaey, H., see le Roux, P.A. 95, 52
sia and the role of serotonin 95, 12
Engelsbel, S., Mol, B.W.J., Hajenius, P.J., Ankum, W.M., van der Veen, F.,
Pharmacological treatment of severe hypertension in pregnancy and the role
Hemrika, D.J., Bossuyt, P.M.M., Non-invasive management of patients
of serotoninz-receptor blockers 95, 22
with suspected ectopic pregnancy: a survey among Dutch gynaecolo-
Bossuyt, P.M.M., see Engelsbel, S. 95, 81
gists 95, 81
Boulanger, J.C., Gondry, J., Verhoest, P., Capsie, C., Najas, S., Treatment of Ergenell, M.H., see Ergin, T. 95, 37
CIN after menopause 95, 175
Ergin, T., Baltaci, V., Zeyneloglu, H.B., Duran, E. Hakan, Ergenell, M.H.,
Bozzo, M., Carpani, G., Leo, L., Marcozzi, S., Sacchi, E., Moroni, G., Pardi,
Batioglu, S.V., Non-invasive early prenatal diagnosis using fluorescent in
G., HELLP syndrome and factor V Leiden 95, 55
situ hybridization on transcervical cells: comparison of two different
Braunberger, E., see Berger, A. 95, 111
methods for retrieval 95, 37
Bréart, G., see Merviel, P. 95, 59
Eskes, T.K.A.B., Clotting disorders and placental abruption: homocysteine
— anew risk factor 95, 206
Capsie, C., see Boulanger, J.C. 95, 175
Evers, J.L.H., see Curvers, J. 95, 222
Carnot, F., see Berger, A. 95, 111
Carpani, G., see Bozzo, M. 95, 55
Chalmers, J., see Chard, T. 95, 114 Faas, M.M., Schuiling, G.A., Pre-eclampsia and the inflammatory
Chard, T., Penney, G., Chalmers, J., The risk of neonatal death in relation to response 95, 213
Fras, P.-A., see UrSi€ VrScaj, M. 95, 105
birth weight and maternal hypertensive disease in infants born at 24-32
weeks 95, 114 Frusca, T., see Soregaroli, M. 95, 42
Fujii, S., see Inoue, T. 95, 184
Chatenoud, L., see Di Cintio, E. 95, 132
Chihara, J., see Tsuda, A. 95, 159 Fukuoka, M., see Inoue, T. 95, 184
Coleman, M.A.G., Keelan, J.A., McCowan, L.M.E., Townend, K.M.,
Mitchell, M.D., Predicting preterm delivery: comparison of cervicova- Garfield, R.E., see Vedernikov, Y.P. 95, 46
ginal interleukin (IL)-1, IL-6 and IL-8 with fetal fibronectin and cervical Gaudet, R., see Merviel, P. 95, 59
dilatation 95, 154 Gomez-Lopez, T., see Sanz, E. 95, 127
Collinet, P., see Cosson, M. 95, 73 Gondry, J., see Boulanger, J.C. 95, 175
Cosson, M., Collinet, P., Occelli, B., Narducci, F., Crépin, G., The vaginal Guibourdenche, J., see Merviel, P. 95, 59
patch plastron for vaginal cure of cystocele. Preliminary results for 47
patients 95, 73 Hajenius, P.J., see Engelsbel, S. 95, 81
Creatsas (Professor), G., see Liapis, A. 95, 97 Hamulyak, K., see Curvers, J. 95, 222
PII: SO301-2115(01)00326-8
234 Author index
Hardwick, J.C.R., Nurturing the Premature Infant. Developmental Inter- Panidis, D.K., Matalliotakis, I.M., Rousso, D.H., Kourtis, A.L.,
ventions in the Neonatal Intensive Care Nursery. E. Goldson, (Ed.), Koumantakis, E.E., The role of estrogen replacement therapy in
Oxford University Press, New York, 1999 95, 138 Alzheimer’s disease 95, 86
Helmerhorst, F.M., see Bloemenkamp, K.W.M. 95, 225 Parazzini, F., see Di Cintio, E. 95, 132
Hemrika, D.J., see Engelsbel, S. 95, 81 Pardi, G., see Bozzo, M. 95, 55
Hoffman, L., see le Roux, PA. 95, 52 Peeters, L.L.H., Thrombophilia and fetal growth restriction 95, 202
Peeters, L.L.H., see Spaanderman, M.E.A. 95, 218
Ikegami, T., see Tsuda, A. 95, 159 Penney, G., see Chard, T. 95, 114
Inoue, T., Matsumura, N., Fukuoka, M., Sagawa, N., Fujii, S., Severe Peters, W.H.M., see Raijmakers, M.T.M. 95, 226
congenital cytomegalovirus infection with fetal hydrops in a cytomega- Poppe, W.A.J., see Van Calenbergh, $.G.K. 95, 182
lovirus-seropositive healthy woman 95, 184 Prifti, S., see Sillem, M. 95, 167
Jauckus, J., see Sillem, M. 95, 167 Raijmakers, M.T.M., Zusterzeel, P.L.M., Steegers, E.A.P., Peters, W.H.M..,
Hyperhomocysteinaemia: a risk factor for preeclampsia? 95, 226
Keelan, J.A., see Coleman, M.A.G. 95, 154 Robic¢, V., see Ursié Vrscaj, M. 95, 105
Khan, K.S., Dinnes, J., Kleijnen, J., Systematic reviews to evaluate diag- Rockenbauer, M., see Czeizel, A.E. 95, 119
nostic tests 95, 6 Rodeck, C.H., see le Roux, P.A. 95, 52
Kleijnen, J., see Khan, K.S. 95, 6 Ronde, H.D., see Bloemenkamp, K.W.M. 95, 225
Koch, A., see Sillem, M. 95, 167 Rosing, J., Curvers, J., Tans, G., Oral contraceptives, thrombosis and
Koukouras, D., see Vorgias, G. 95, 100 haemostasis 95, 193
Koumantakis, E.E., see Panidis, D.K. 95, 86 Rosing, J., see Curvers, J. 95, 222
Kourtis, A.I., see Panidis, D.K. 95, 86 Rousso, D.H., see Panidis, D.K. 95, 86
Kovacié, J., see Ursi¢ Vrscaj, M. 95, 105 Rouzier, R., see Berger, A. 95, 111
Kuczynski, J., see Uszynski, M. 95, 163 Runnebaum, B., see Sillem, M. 95, 167
La Vecchia, C., see Di Cintio, E. 95, 132 Saade, G.R., see Vedernikov, Y.P. 95, 46
le Roux, P.A., Pahal, G.S., Hoffman, L., Nooh, R., El-Refaey, H., Rodeck, Sacchi, E., see Bozzo, M. 95, 55
C.H., Second trimester termination of pregnancy for fetal anomaly or Sagawa, N., see Inoue, T. 95, 184
death: comparing mifepristone/misoprostol to gemeprost 95, 52 Sanz, E., Gomez-Lopez, T., Martinez-Quintas, M.J., Perception of terato-
Leo, L., see Bozzo, M. 95, 55 genic risk of common medicines 95, 127
LeskoSek, B., see Verdenik, I. 95, 149 Scalvi, L., see Soregaroli, M. 95, 42
Liapis, A., Bakas, P., Creatsas (Professor), G., The efficacy of bladder Scapillati, M.E., see Zuppa, A.A. 95, 68
distention therapy in the treatment of frequency and urgency 985, Schellekens, L.A., Thrombophilia and reproduction Introduction 95, 188
97 Schuiling, G.A., see Faas, M.M. 95, 213
Sillem, M., Prifti, S., Koch, A., Neher, M., Jauckus, J., Runnebaum, B.,
Maragliano, G., see Zuppa, A.A. 95, 68 Regulation of matrix metalloproteinases and their inhibitors in uterine
Marcozzi, S., see Bozzo, M. 95, 55 endometrial cells of patients with and without endometriosis 95, 167
Martinez-Quintas, M.J., see Sanz, E. 95, 127 Soregaroli, M., Valcamonico, A., Scalvi, L., Danti, L., Frusca, T., Late
Matalliotakis, I.M., see Panidis, D.K. 95, 86 normalisation of uterine artery velocimetry in high risk pregnancy 95,
Matsumura, N., see Inoue, T. 95, 184 42
McCowan, L.M.E., see Coleman, M.A.G. 95, 154 Spaanderman, M.E.A., Aardenburg, R., Ekhart, T.H.A., van Eyndhoven,
Merviel, P., Miiller, F., Guibourdenche, J., Berkane, N., Gaudet, R., Bréart, H.W.F., van der Heijden, O.W.H., van Eyck, J., de Leeuw, P.W., Peeters,
G., Uzan, S., Correlations between serum assays of human chorionic L.L.H., Non-pregnant circulatory volume status predicts subsequent
gonadotrophin (hCG) and human placental lactogen (hPL) and pre- pregnancy outcome in normotensive thrombophilic formerly preeclamp-
eclampsia or intrauterine growth restriction (IUGR) among nulliparas tic women 95, 218
younger than 38 years 95, 59 Sorensen, H.T., see Czeizel, A-E. 95, 119
Mitchell, M.D., see Coleman, M.A.G. 95, 154 Steegers, E.A.P., see Raijmakers, M.T.M. 95, 226
Mol, B.W.J., see Engelsbel, S. 95, 81 Surace, M., see Di Cintio, E. 95, 132
Moroni, G., see Bozzo, M. 95, 55
Miiller, F., see Merviel, P. 95, 59 Tanaka, T., see Tsuda, A. 95, 159
Tans, G., see Rosing, J. 95, 193
Najas, S., see Boulanger, J.C. 95, 175 Thornton, J.G., Editorial 95,5
Nap, A.W., see Curvers, J. 95, 222 Tortorolo, G., see Zuppa, A.A. 95, 68
Narducci, F., see Cosson, M. 95, 73 Townend, K.M., see Coleman, M.A.G. 95, 154
Neher, M., see Sillem, M. 95, 167 Tsubaki, H., see Tsuda, A. 95, 159
Nienhuis, S.J., see Curvers, J. 95, 222 Tsuda, A., Ikegami, T., Ogawa, M., Tsubaki, H., Obara, M., Tanaka, T.,
Nooh, R., see le Roux, PA. 95, 52 Urayama, O., Chihara, J., Effect of reactive oxygen species on fetal lung
Nwobodo, E., see Orisakwe, O.E. 95, 92 maturation 95, 159
Tzoracoeleftherakis, E., see Vorgias,G. 95, 100
Obara, M., see Tsuda, A. 95, 159
Occelli, B., see Cosson, M. 95, 73 Urayama, O., see Tsuda, A. 95, 159
Ogawa, M., see Tsuda, A. 95, 159 UrSié Vr8Caj, M., Kovacié, J., Bebar, S., Djurisi¢, A., Fras, P.-A., Robi¢, V.,
Olsen, J., see Czeizel, ALE. 95, 119 Endometrial and other primary cancers after tamoxifen treatment of
Orisakwe, O.E., Afonne, O.J., Nwobodo, E., Asomugha, L., Dioka, C.E., breast cancer — results of retrospective cohort study 95, 105
Low-dose mercury induces testicular damage protected by zinc in Uszyriski, M., Zekanowska, E., Uszyriski, W., Kuczyriski, J., Tissue factor
mice 95, 92 (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and
blood plasma: implications for the mechanism of amniotic fluid embo-
Pahal, G.S., see le Roux, PA. 95, 52 lism 95, 163
Pajntar, M., see Verdenik, I. 95, 149 Uszynski, W., see Uszynski, M. 95, 163
Paleogianni, V., see Vorgias,G. 95, 100 Uzan, S., see Merviel, P. 95, 59
Author index 235
Valcamonico, A., see Soregaroli, M. 95, 42 Verdenik, I., Pajntar, M., LeskoSek, B., Uterine electrical activity as
Van Calenbergh, F., see Van Calenbergh, $.G.K. 95, 182 predictor of preterm birth in women with preterm contractions 95, 149
Van Calenbergh, S.G.K., Poppe, W.A.J., Van Calenbergh, F., An intracranial Verhoest, P., see Boulanger, J.C. 95, 175
tumour — an uncommon cause of hyperemesis in pregnancy 95, 182 Vierhout, M.E., Voiding dysfunction: diagnosis and treatment. Rodney A.
van der Heijden, O.W.H., see Spaanderman, M.E.A. 95, 218 Appell (Ed.), Humana Press, US$ 99.50, ISBN 0-896-03659-6 95, 138
van der Mooren, M.J., The menopause: comprehensive management. B.A. Vorgias, G., Koukouras, D., Paleogianni, V., Tzoracoeleftherakis, E., Prog-
Eskin (Ed.), Parthenon Publishing, 25 Blades Court, Deodar Road, nostic significance of factors affecting disease free interval and overall
London SW15 2NU, ISBN: 1-85070-090-7, March 2000-06-18, US $ survival for Stage II breast cancer in Greece. A multivariate cohort
78.00, £45, 311 pp. 95, 137 study 95, 100
van der Veen, F., see Engelsbel, S. 95, 81
van Eyck, J., see Spaanderman, M.E.A. 95, 218 Wen, T.S., see Vedernikov, Y.P. 95, 46
van Eyndhoven, H.W.F., see Spaanderman, M.E.A. 95, 218
van Geijn, H.P., see Bolte, A.C. 95, 12, 22 Zanconato, G., see Di Cintio, E. 95, 132
van Hinsbergh, V.W.M., The endothelium: vascular control of haemosta- Zekanowska, E., see Uszynski, M. 95, 163
sis 95, 198 Zeyneloglu, H.B., see Ergin, T. 95, 37
Vedernikov, Y.P., Saade, G.R., Belfort, M.A., Wen, T.S., Garfield, R.E., The Zuppa, A.A., Maragliano, G., Scapillati, M-E., Crescimbini, B., Tortorolo, G.,
effect of 17{-estradiol on isolated omental arteries from preeclamptic Neonatal outcome of spontaneous and assisted twin pregnancies 95, 68
women 95, 46 Zusterzeel, P.L.M., see Raijmakers, M.T.M. 95, 226
EUROPEAN JOURNAL OF
OBSTETRICS &
Mev)
GYNECOLOGY
ey
ELSEVIER European Journal of Obstetrics & Gynecology and AND REPRODUCTIVE BIOLOGY
Reproductive Biology 95 (2001) 236-237
www.elsevier.com/locate/ejogrb
Subject index
Volume 95 (2001)
17B-Estradiol 95, 46 Fetal lung maturation 95, 159
677(C — T) polymorphism in MTHFR 95, 226 Fibrin olysis 95, 198
Abnormalities 95, 127 Foetal development 95, 127
Adenocarcinoma 95, 111 Frequency 95, 97
Alzheimer’s disease 95, 86
Amniotic fluid 95, 163 Genital prolapse 95, 73
Angiogenesis 95, 198 Growth retardation 95, 114
Antihypertensive drugs in pregnancy 95, 22
Antithrombotic properties 95, 198 Haemostasis 95, 198
APC resistance 95, 193, 222 HELLP syndrome 95, 55
Assisted reproduction 95, 68 Hemodynamic 95, 218
Attitude to health 95, 127 Homocysteine 95, 206, 226
Hormone replacement therapy 95, 86
Birth weight 95, 114 Human chorionic gonadotrophin (hCG) 95, 59
Bladder distention therapy 95, 97 Human omental artery 95, 46
Blastocyst 95, 213 Human placental lactogenic hormone (hPL) 95, 59
Blood plasma 95, 163 Human teratogenic potential 95, 119
Brain tumour 95, 182 Hyperemesis gravidarum 95, 182
Brain 95, 86
Breast cancer 95, 100, 105 Immunohistochemical staining 95, 111
Implantation 95, 213
Calcium channel inhibition 95, 46 Implementation 95, 81
Case-control analysis 95, 119 Infant, small-for-gestational-age 95, 114
Cell culture 95, 167 Inflammatory response 95, 213
Cervical intraepithelial neoplasia 95, 175 Intrauterine growth retardation 95, 59
Cervicovaginal cytokines 95, 154 IVF treatment 95, 222
Chorioamnionitis 95, 159
Clotting disorders 95, 206 Ketanserin 95, 22
Coagulation 95, 198
Complications 95, 181 Leukocytes 95, 213
Congenital abnormalities 95, 119
Congenital infection 95, 184 Matrix metalloproteinases 95, 167
Conization 95, 175 Mercury 95, 92
Cystocele 95, 73 Misoprostol 95, 52
Cytomegalovirus 95, 184 Multicolor FISH 95, 37
Multiple pregnancies 95, 68
Diet 95, 132 Myotonic dystrophy 95, 181
Doppler 95, 59
Drug effects 95, 127 Neonatal death 95, 114
Drug therapy 95, 127 Nitrofurantoin 95, 119
Drug-induced 95, 127 Non-invasive diagnosis 95, 81]
Non-invasive prenatal diagnosis 95, 37
Ectopic pregnancy 95, 81
Endometrial cancer 95, 105 Oral contraceptives 95, 193, 222
Endometriosis 95, 111, 167
Endometrium 95, 167 Pathogenesis 95, 167
Endothelium 95, 198 Pathophysiology of preeclampsia 95, 12
Epidemiology 95, 132 Perceptions 95, 127
Epididymal sperm number 95, 92 Placental abruption 95, 206
Estrogen 95, 86 Plasma volume 95, 218
Estrogens 95, 222 Post menopausal 95, 175
Etiology 95, 127 Pre-eclampsia 95, 114, 59
Pre-edampsia 95, 213
Factor V Leiden 95, 55, 193 Pre-pregnant 95, 218
Fetal growth restriction 95, 218 Prediction 95, 218
PII: SO301-2115(01)00327-X
Subject index
Preeclampsia 95, 12, 218, 226, 46, 55 Stage II 95, 100
Pregnancy complications 95, 127, 42 Steinert’s disease 95, 181
Pregnancy induced hypertension 95, 114 Surfactant associated protein 95, 159
Pregnancy 95, 163, 181, 182, 184, 213
Pregnancy-induced hypertension 95, 59 Tamoxifen 95, 105, 46
Premature birth 95, 68 Termination 95, 52
Prenatal diagnosis 95, 184 Testicular damage 95, 92
Preterm birth 95, 149 Thrombophilia 95, 218
Preterm contractions 95, 149 Tissue factor (TF) 95, 163
Preterm delivery 95, 114, 154 Tissue factor pathway inhibitor (TFPI) 95,
Preterm labour 95, 154 Transcervical cells 95, 37
Prognostic factors 95, 100 Treatment 95, 175
Puerperium 95, 181
Urgency 95, 97
Reactive oxygen species 95, 159 Urinary stress incontinence 95, 73
Rectovaginal septum 95, 111 Uterine artery velocimetry 95, 42
Risk factors 95, 127, 132 Uterine electrical activity 95, 149
Second trimester 95, 52 Vaginal plastron 95, 73
Serotonin and preeclampsia 95, 12 Venous thrombosis 95, 193, 222
Serotonin,-receptor blocker 95, 22 Vomiting 95, 182
Small for gestational age fetuses 95, 42
Small for gestational age 95, 68 Xanthine oxidase 95, 159
Small-for-gestational-age 95, 114
Spontaneous abortion 95, 132 Zine 95, 92